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Abstract.  We examined the uptake and intracellular 
transport of the fluorescent glucosylceramide analogue 
N-[5-(5,7-dimethyl BODIPY'~)-l-pentanoyl]  -glucosyl 
sphingosine (CrDMB-GlcCer) in human skin fibro- 
blasts, and we compared its behavior to that of the 
corresponding fluorescent analogues of sphingomyelin, 
galactosylceramide, and lactosylceramide. All four 
fluorescent analogues were readily transferred from 
defatted BSA to the plasma membrane during incuba- 
tion at 4°C.  When cells treated with CrDMB-GlcCer 
were washed, wanned to 370C,  and subsequently in- 
cubated with defatted BSA to remove fluorescent lipid 
at the cell surface, strong fluorescence was observed at 
the Golgi apparatus, as well as weaker labeling at the 
nuclear envelope and other intracellular membranes. 
Similar results were obtained with Cs-DMB-galac- 
tosylceramide, except that labeling of the Golgi ap- 
paratus was weaker than with Cs-DMB-GlcCer. Inter- 
nalization of Cs-DMB-GlcCer was not inhibited by 
various treatments, including ATP depletion or wann- 
ing to  190C, and biochemical analysis demonstrated 
that the lipid was not metabolized during its internal- 
ization. However, accumulation of Cs-DMB-GlcCer at 
the Golgi apparatus was reduced when cells were 
treated with a nonfluorescent analogue of glucosylcera- 
mide, suggesting that accumulation of Cs-DMB- 
GlcCer at the Golgi apparatus was a saturable process. 
In contrast, cells treated with CrDMB-analogues of 
sphingomyelin or lactosylceramide internalized the 
fluorescent lipid into a punctate pattern of fluores- 
cence during warming at 37°C, and this process was 
temperature and energy dependent. These results with 
CrDMB-sphingomyelin and Cs-DMB-lactosylceramide 
were analogous to those obtained with another fluores- 
cent analogue of sphingomyelin in which labeling of 
endocytic vesicles and plasma membrane lipid recy- 
cling were documented (Koval, M., and R. E. Pagano. 
1990. J.  Cell Biol.  111:429--442).  Incubation of perfo- 
rated cells with Cs-DMB-sphingomyelin resulted in 
prominent labeling of the nuclear envelope and other 
intracellular membranes, similar to the pattern ob- 
served with CrDMB-GIcCer in intact cells. These ob- 
servations are consistent with the transbilayer move- 
ment of fluorescent analogues of glucosylceramide and 
galactosylceramide at the plasma membrane and early 
endosomes of human skin fibroblasts, and suggest that 
both endocytic and nonendocytic pathways are used in 
the internalization of these lipids from the plasma 
membrane. 
LYCOSPHINGOLIPIDS (GSLs) ~ are  constituents  of 
the plasma membranes of all eukaryotic cells and 
play important roles in cell-cell interactions, modu- 
lation  of cell growth and differentiation,  and intracellular 
signaling. The backbone of GSLs is synthesized at the endo- 
plasmic reticulurn and subsequently transported to the Golgi 
Address all correspondence  to Richard E. Pagano, Department of Embryol- 
ogy, Carnegie Institution of  Washington, 115 West University  Parkway,  Bal- 
timore, MD 21210-3399. 
1. Abbreviations used in this paper: BODIPY  TM, boron dipyrromethene di- 
fluoride; C2-GalCer, N-acetyl-gaiactosyl  sphingosine; C2-GlcCer, N-acetyl- 
glucosyl  sphingosine;  Cs-DMB-Cer, N-[5-(5,7-chm'  ethyl  BODIPY")-I- 
pentanoyl]D-erythro-sphlngosine;  Cs-DMB-GaiCer, Cs-DMB-galactosyl 
sphingosine; Cs-DMB-GlcCer, Cs-DMB-glucosyl  sphlngosine; Cs-DMB- 
La¢Cer, Cs-DMB-lactosyl sphingosine; Cs-DMB-SM, C~-DMB-sphin- 
gosylphosphorylcholine; Ct-GalCer, N-hexanoyl-galactosyl  sphingosine; 
Ct-GIcCer, N-hexanoyl-glucosyl  sphingosine; Ct-NBD-GIcCer, N-(N-[6- 
[(7-nitrobenz-2-oxa-l,3  -diazol-4-yl)amino]  hexanoyl])glucosyl  sphingosine; 
Cer, ceramide; GlcCer, glucosylceramide; DF-BSA, defatted BSA; GSL, 
glycosphingolipid;  HMEMB, 10 mM 4-(2-hydroxyethyl)-l-piperazineethane 
sulfi3aic  acid-buffered  MEM, pH 7.4, without indicator, and containing 0.5 
mM each choline chloride, ethanolamine, serine, and (myo)inositol; Lac- 
Cer, lactosylceramide; SM, sphingomyelin. 
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are then transported to the cell surface in a manner analo- 
gous to movement of newly synthesized membrane proteins 
along the secretory pathway. Once delivered to the cell sur- 
face, GSLs are thought to undergo multiple rounds of recy- 
cling between the plasma membrane and endosomes, and are 
slowly  transported  along  the  endocytic  pathway tO  lyso- 
somes, where they are hydrolyzed to sphingosine and fatty 
acids. The reader is referred to recent reviews for further dis- 
cussion of various aspects of GSL metabolism, transport, 
and function (Hannun and Bell,  1989;  Merrill and Stevens, 
1989; Hakomori,  1990; Schwarzmann and Sandhoff,  1990; 
Pagano,  1990a; Kolesnick,  1991; Hoekstra and Kok,  1992; 
van Echten and Sandhoff, 1993; van Meer, 1993; Rosenwald 
and Pagano,  1993). 
In the present study, we examined the intracellular trans- 
port of a fluorescent glycolipid analogue,  glucosylceramide 
(N-[5-(5,7-dimethyl BODIPY~)-l-pentanoyl]-gl¢cosyl  sphin- 
gosine [Cs-DMB-GlcCer]),  following its insertion  into the 
plasma membrane bilayer of human skin fibroblasts to learn 
more about the possible mechanisms by which endogenous 
GSLs may be transported between the cell surface and intra- 
cellular membranes.  In contrast to sphingomyelin,  which is 
internalized  via endocytic vesicles  and undergoes plasma 
membrane lipid recycling  (Koval and Pagano,  1989,  1990, 
1991; Mayor et al.,  1993), we found that Cs-DMB-GIcCer 
was internalized  by both endocytic  and nonendocytic  path- 
ways,  resulting  in  labeling  of various intracellular  mem- 
branes and accumulation at the Golgi apparatus. These data 
and complementary experiments with Cs-DMB-GalCer  and 
Cs-DMB-lactosyl  sphingosine  (Cs-DMB-LacCer)  suggest 
that different pathways for the transport of endogenous GSLs 
from the plasma membrane to intracellular membranes may 
be used depending on the GSL headgroup. Our data also pro- 
vide a plausible mechanism for the sorting of fluorescent an- 
alogues of sphingomyelin  and glucosylceramide from each 
other  during  endocytosis,  which was previously observed 
using HT29 cells (Kok et al.,  1991). 
Materials and Methods 
Cells and Cell Culture 
Normal (GM5659) and Gaucher's type II disease (GM1260)  human skin 
fibroblasts were obtained from the Corieli Institute, Human Genetic Mutant 
Cell Repository (Camden, NJ). The cells were grown in Eagle's MEM sup- 
plemented with 10% FBS, 2 mM L-glutamine,  100 U/ml penicillin, 100 
#g/ml streptomycin,  and 0.1 mM each nonessential amino acids. 
Cells were grown on no. 1 thickness glass coverslips for fluorescence mi- 
croscopy  or  in 35-ram  diameter tissue culture  dishes  for biochemical 
studies.  All cells were grown at 37°C in a water-saturated  atmosphere of 
5 % CO2 in air. 
Lipids 
Cs-DMB-sphingosylphospborylcholine (Cs-DMB-SM), Cs-DMB-v-erythro- 
sphingosine (Cs-DMB-Cer), and Cs-DMB-fatty  acid were obtained from 
Molecular Probes,  Inc. (Eugene, OR).  C5-DMB-GIcCer, Cs-DMB-GalCer, 
and Cs-DMB-LacCer were  prepared by N-acylation  (Schwat'zmann  and 
Sandhoff,  1987)  of glucopsychosine,  psychosine,  and "lyso-LacCer" (a 
generous girl from Dr. G. Schwatzmann, University of Bonn, Bonn, Ger- 
many),  respectively,  using the N-hydroxysuccinimide  ester  of the  Cs- 
DMB-fatty  acid.  Nonfluorescent,  short-chain analogues  of glucosylcera- 
mide (GlcCer) and galactosylceramide  (GalCer) were prepared in a similar 
manner using the N-bydroxysuccinimidyl  esters of acetic acid and bexanoic 
acid. The sphingolipids were purified by preparative thin-layer chromatog- 
raphy using CHC13/MeOH/15 mM CaCh (60:35:8, vol/vol/vol) as the de- 
veloping solvent. 
The concentration of the Cs-DMB-SM stock solution was determined 
by phosphorus analysis  (l~user et al.,  1981). The concentrations of Cs- 
DMB-GIcCer,  Cs-DMB-GalCer,  Cs-DMB-LacCcr,  and  Cs-DMB-Cer 
stock solutions were determined by measuren~nt of their fluorescence  in- 
tensities relative to Cs-DMB-SM, using CHCI3/MeOH  (2:1, vol/vol) as the 
solvent.  (The ratio of fluorescence  to absorbance at 508 nm was the same 
for all five lipids.) Fluorescence measurements were per~rmed using an 
SLM 8000C spectrophotofluorimoter  (SLM Instruments, Inc., Urbana, IL) 
(~  =  480 nm; ~rn =  516 nm). 
Sphingolipid/BSA Complexes 
Complexes  of  Cs-DMB-Cer,  Cs-DMB-GlcCer,  Cs-DMB-C.mlCer, C5- 
DMB-LacCer,  and Cs-DMB-SM  were prepared as described (Pageno and 
Martin, 1988), except that the complexes contained 25/~M each of fluores- 
cent lipid and BSA. Briefly, 250 nmol of the desired Cs-DMB-lipid  in a 
CHCIs/MeOH stock solution was dried, first under a stream of nitrogen 
and then in vacuo. The dried lipid was dissolved in 200 #1 of ethanol and 
injected into  10 ml of HMEMB containing 1.7 mg defatted  BSA (DF- 
BSA)/ml while being vortex mixed.  The complex was dialyzed overnight 
at 4°C against 500 ml of 10 mM 4-(2-hydroxyethyl)-l-piperazineethane  sul- 
foulc acid-buffered MEM, pH 7.4,  without indicator and containin$ 0.5 
mM  each  choline,  chloride,  ethanolamine,  serine,  and  (myo)inositol 
(HMEMB) and then frozen at  -20°C in plastic tubes.  Before  use, the 
complexes were diluted with HMEMB as required.  Complexes of  N-acetyl- 
glucosyl  sphingosine (C2-GlcCer) or N-acetyl-gelactosyl  sphingosine (C2- 
GalCer) and N-hexanoyl-glucosyl  sphingosine (Ct-GIcCer) or N-hexanoyl- 
galactosyl  sphingosine (Ct-OalCer) were prepared in a  similar manner, 
except that the ratio of lipid to BSA was 2:1 (mol/mol). 
Incubaffon of  Fluorescent Lipids with Cells 
Cultures were washed in HMEMB, incubated  with 2.5, 5, or 10/~M (as indi- 
eated)  Cs-DMB-sphingolipid/DtLBSA  in HMEMB  for 30 min at 2°C, 
washed, and further incubated in HMEMB for 0-30 rain at 37°C. In some 
experiments,  the cultures were chilled and incubated at II°C (six times, 10 
min each) with HMEMB containing  2 % DF-BSA ("back exchange") or with 
HMEMB alone before photography or biochomicni analysis. 
In biochemical experiments,  cells were harvested after the appropriate 
incubation using a  rubber policeman,  washed  by centrifugetion,  resus- 
pended,  and  aliquots  were  removed  for protein content determination 
(Lowry et al.,  1951) and for lipid extraction 08ligh and Dyer,  1959). The 
relative fluorescence  of the lipid extracts was determined (k~ ffi 495 nm; 
Table L Uptake and Back Exchange of C~-DMB-GIcCer, 
Cs-DMB-GalCer, and Cs-DMB-SM  from Human 
Skin Fibroblasts* 
Lipid labeling  Percent remaining 
concentration*  Uptake  after back exchange 
pmol CrDMB-lipid/l~g  protein 
Cs-DMB-GIcCer 
5  #M  0.148  +  0.017  25.7  +  3.5 
10 #M  0.208  +  0.012  27.9  -1- 4.2 
Cs-DMB-GalCer 
5 #M  0.227  +  0.016  5.3  +  1.3 
C5-DMB-SM 
5 #M  0.262  +  0.020  5.3  +  0.5 
* Cells were incubated with the indicated concentration of Cs-DMB-GIcCer, 
Cs-DMB-GalCer,  or  Cs-DMB-SM/DF-BSA complex  for  30  min  at 2°C, 
washed, and the fipids were extracted, quantified, and normalized to cellular 
protein. Some of the labeled cells were back exchanged by incubating with 2% 
DF-BSA (6 ×  10 min at 11 °C; see Materials and Methods) before lipid extrac- 
tion and analysis. (A sufficient amount of Cs-DMB-LacCer was not available 
for quantitative studies.) Data represent means +  SD (n =  3). 
* Parallel cultures incubated with 10 ~M Cs-DMB-OlcCer, 5 t~M Cs-DMB- 
GalCer, or 5 #M C~-DMB-SM/DF-BSA for 30 min at 2°C were washed and 
observed under the fluorescence microscope in the green and red channel (see 
Materials and Methods). The color of the plasma membrane was orange in all 
three cases, and these labeling concentrations were used for Fig. 2. 
The Journal of Cell Biology, Volume 125, 1994  770 Figure 1.  Redistribution  of Cs-DMB-GIcCer from the plasma membrane to intracellular  membranes with time at 37°C.  Cells were in- 
cubated with Cs-DMB-GIcCer/BSA complex for 30 rain at 2°C, washed,  warmed for (A) 0, (B) 5, (C) 15, or (D) 30 min at 37°C, and 
subsequently  "back exchanged"  (see Materials  and Methods).  Separate photomicrographs of a given field were obtained at green +  red 
wavelengths  (/eft panels,  3520 nm) and red wavelengths  (right pane/s,  3590 nm). Note the redistribution  of fluorescence to numerous 
intracellular membranes including  the Golgi apparatus in (C) and (D).  Bar,  10/~m. hem =  515 nm) and normalized to the protein content. The amounts of 
fluorescent Cs-DMBqipid present in the cell extracts were determined by 
standard  curves  generated  from  lipid  extracts,  prepared  from  various 
amounts of each Cs-DMB-lipid/BSA  complex.  Lipid extracts  were also 
analyzed qualitatively by thin-layer chromatography. 
Miscellaneous Procedures 
For experiments  using perforated cells, cells were washed with HMEMB, 
perforated by filter stripping (Simons  and Virta,  1987;  Kobayashi  and 
Pagano,  1988),  labeled  with  5  ~tM  Cs-DMB-lipid/BSA  in  transport 
medium (see Gravotta et al., 1990) for 15 rain at 2°C, washed in transport 
medium, and photographed. 
Cells were treated with inhibitors as described in the second footnote of 
Table II. 
Control cells or ATP-depleted cells (see Table II, second footnote) were 
incubated for 30 rain at 37"C with 1 mg/ml Texas red-labeled dextran (10 
kD; Molecular Probes, Inc.) in the absence (control) or presence (ATP 
depleted) of inlfibitors, washed,  and observed by fluorescence  microscopy. 
Fluorescence microscopy  was performed with an inverted microscope 
0M-35; Carl Zeiss, Inc., Thornwood,  NY) equipped with a Planapo 100X 
(1.3 NA) objective and epithorescence optics.  Samples  were excited  at 
450-490 nm, and the fluorescence  observed at either ~520 nm (green + 
red wavelengths) or at ;~590 um (red wavelengths) (see Pagano et al,, 1991). 
Photomicrographs representative of observations of large numbers of cells 
in each sample were obtained either in color using Kodak Ektachrome 400 
film (4-s exposure),  which was pushed one stop during processing,  or black 
and white using Kodak Tri-X film (4-s exposure)  and processed at AS& 
1600 with a developer (Dialine; At:urine, Chicago,  IL). All micrographs 
from a given experiment were printed identically. 
Results 
Uptake and Back Exchangeability of 
CrDMB-labeled Lipids 
We  first  examined  the  uptake  of  Cs-DMB-GlcCer,  Cs- 
DMB-GalCer,  and  Cs-DMB-SM using  equal  concentra- 
tions of  the fluorescent lipid/DF-BSA complexes. Cells were 
incubated  with  5  /zM  C5-DMB-lipid/BSA for 30  rain at 
20C, washed, and the lipids were extracted and quantified. 
The amount of cell-associated Cs-DMB-SM and Cs-DMB- 
GalCer were nearly equal,  but were considerably  greater 
than the amount of cell-associated  Cs-DMB-GIcCer. This 
difference in uptake was diminished by increasing the con- 
centration  of Cs-DMB-GlcCer/BSA to  10  /~M  (Table I). 
When cells treated under these conditions were examined 
under the fluorescence microscope, only plasma membrane 
fluorescence  was detected,  and the fluorescence emission 
was orange in each case.  Since the fluorescence emission 
spectrum  of  C5-DMB-lipids  is  concentration  dependent 
(Pagano et al.,  1991), these observations  suggest that the 
different CrDMB-lipid species had similar "local" concen- 
trations in the plasma membrane bilayer. 
We also  examined the ability of each  of the C5-DMB- 
lipids to be removed from the plasma membrane by incuba- 
tion with a nonfluorescent acceptor  (back exchange). Both 
Cs-DMB-GalCer and Cs-DMB-SM were almost completely 
removed by incubation  with DF-BSA, while significantly 
more of the Cs-DMB-GlcCer taken up by cells at 20C re- 
mained cell associated after back exchange. This result was 
confirmed qualitatively by fluorescence microscopy, in which 
plasma membrane labeling was readily observed after back 
exchange of cells treated with Cs-DMB-GlcCer, but was not 
seen with Cs-DMB-SM or CrDMB-GalCer. Lipid extrac- 
tion and analysis confirmed that the cell-associated fluores- 
cence was from Cs-DMB-GlcCer, and not from a fluores- 
cent metabolite or breakdown product  (data not shown). 
Time Course  for Internalization of CrDMB-GlcCer 
at 37°C 
Fig.  1 shows a time course for redistribution  of Cs-DMB- 
fluorescence  from the plasma  membrane  to intracellular 
membranes.  Cells  were  incubated  with  Cs-DMB-GlcCer/ 
BSA for 30 rain at 2°C, washed, warmed to 37°C for various 
times, back exchanged at 10°C, and observed at either >-520 
nm (left panels, green + red wavelengths) or at >-590 nm 
(right panels, red wavelengths) (see Pagano et al.,  1991). 
When cells were observed at >-520 nm, fluorescence was ini- 
tially seen only at the plasma membrane  (Fig. 1 A). After 
5 rain at 37°C the fluorescence was also seen in "dotlike" 
structures scattered throughout the cytoplasm (Fig. 1 B). By 
15-30 rain of incubation,  almost all of the cell-associated 
fluorescence was seen at the Golgi apparatus, nuclear enve- 
lope, and other intracellular membranes (Fig. 1, C and D). 
When the same cells were observed at red wavelengths so 
that only membranes containing high concentrations of the 
CrDMB-lipids were seen (see Pagano et al., 1991), redis- 
tribution of fluorescence from the plasma membrane to en- 
dosomes, and later to the Golgi apparatus, was seen (Fig. 1, 
right panels).  However, no labeling of the ER or plasma 
membrane was detected in the red microscope channel, sug- 
gesting  that  the  concentration  of the  Cs-DMB-lipids  in 
these membranes was relatively low. 
We next compared the uptake and distribution of Cs-DMB- 
GlcCer,  Cs-DMB-GalCer,  Cs-DMB-SM,  and  Cs-DMB- 
LacCer in human skin fibroblasts (Fig. 2).  Cells were in- 
cubated with these lipids for 30 rain at 2°C, washed, wanned 
to 37°C for 15 rnin, back exchanged, and then observed un- 
der the fluorescence microscope at green + red wavelengths. 
CrDMB-SM was distributed in a punctate pattern through- 
out the cytoplasm (Fig. 2 A), and, by analogy to previous 
studies using another fluorescent analogue of sphingomyelin 
(K_oval and Pagano, 1990), labeled the endosomes and Golgi 
apparatus. CrDMB-LacCer gave a similar labeling pattern 
to that seen  with C5-DMB-SM (Fig.  2  B).  In contrast, 
treatment with Cs-DMB-GlcCer resulted in strong labeling 
of the Golgi apparatus,  as well as weaker labeling of the 
plasma membrane, nuclear envelope, and other intracellular 
membranes (Fig. 2 C). Some weak labeling of endosomes 
was  also  observed.  Interestingly,  cells  treated  with  Cs- 
DMB-GalCer  exhibited labeling of both vesicle-like struc- 
tures,  as well as numerous other intracellular  membranes, 
including the Golgi apparatus (Fig. 2 D). However, labeling 
of the Golgi apparatus was considerably weaker than when 
CrDMB-GlcCer was used (compare Fig. 2, C vs D). 
Lipid extraction and analysis of  cells that were treated with 
C5-DMB-GlcCer/BSA for  30  rain  at  2°C,  washed,  and 
warmed for 30 rain at 37°C showed that >-98  % of the cell- 
associated  fluorescence  was  from Cs-DMB-GlcCer  (data 
not shown). In addition,  when Cs-DMB-GIcCer/BSA was 
incubated with mutant (Gaucher's) fibroblasts lacking gluco- 
cerebrosidase  (Brady et al.,  1965), an identical pattern of 
labeling to that seen in normal fibroblasts was observed, 
demonstrating that the intracellular  fluorescence seen with 
Cs-DMB-GlcCer was not caused by its hydrolysis. 
Finally, we note that when cells treated with BSA com- 
plexes of Cs-DMB-GaICer, Cs-DMB-LacCer, or Cs-DMB- 
SM were observed at >-520 nm (green +  red wavelengths), 
an interesting pattern of fluorescence labeling of the endo- 
somes was seen. Namely, within the same cell, some endo- 
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 Figure 3. Effect of perforation on the intracellular distribution of 
Cs-DMB-fluorescence. Intact (A) or perforated (B) cells were in- 
cubated with CrDMB-SM/BSA at 2°C, washed, and photographed 
at green +  red wavelengths. Note that CrDMB-SM prominently 
labeled the plasma membrane of intact cells, but resulted in strong 
intracellular labeling when perforated cells were used.  Similar 
results to those shown in  (B)  were obtained when cells were 
pretreated with Cs-DMB-SM/BSA at 2°C and subsequently  perfo- 
rated (data not shown). Bar, 10 ~m. 
somes exhibited green fluorescence, while others emitted or- 
ange fluorescence. In addition, "orange endosomes" were 
sometimes seen at the leading edge of cells. These results 
suggest that different populations of endosomes within the 
same cell may contain different  concentrations of  the fluores- 
cent lipid analogues  (Pagano,  R.  E.,  and O.  C.  Martin, 
manuscript in preparation). 
Distribution of CrDMB-lipids in Perforated Cells 
We  next  examined  the  intracellular  distribution  of  Cs- 
DMB-SM  in  intact vs  perforated  cells.  Cs-DMB-SM  la- 
beled the plasma membrane of intact cells at low tempera- 
ture (Fig. 3 A) and distributed into endocytic vesicles upon 
warming the cells to 37°C (Fig. 2 A). However, when cells 
were perforated before (Fig. 3 B) or after (data not shown) 
incubation with the fluorescent lipid at low  temperature, 
numerous intracellular membranes, including the ER, mito- 
chondria, and nuclear envelope, were labeled.  Similar ex- 
periments  were  performed at  low  temperature using  Cs- 
DMB-GIcCer  and  Cs-DMB-GalCer,  and,  in  both  cases 
(data not shown), the fluorescent lipids labeled the plasma 
membrane of intact cells and the intracellular membranes of 
perforated cells. These results demonstrate that labeling of 
intracellular membranes by Cs-DMB-llpids can occur once 
the lipids cross the plasma membrane bilayer. Indeed, both 
intact  and  perforated  cells  incubated  with  Cs-DMB-Cer 
gave  identical patterns  of intracellular labeling  (data  not 
shown), presumably because ceramide analogues undergo 
spontaneous transbilayer movement (Pagano and Martin, 
1988; Pagano, 1989) and readily cross the plasma membrane 
bflayer of intact cells. 
Effects of  ATP Depletion and Temperature on the 
Intraceilular Distribution of  C,-DMB-GIcCer 
The effect of ATP depletion on the internalization of Cs- 
DMB-SM (Fig. 4) and Cs-DMB-GlcCer (Fig. 5) was exam- 
ined. Control or ATP-depleted cells were incubated with the 
fluorescent lipid for 30 rain at 2°C, washed, warmed to 37°C 
for 30 rain, back exchanged with DF-BSA, and observed at 
either/>520 nm (/eft panels, green + red wavelengths)  or at 
/>590 nm (right panels, red wavelengths). All steps were 
performed in the absence or presence of inhibitors. When 
CrDMB-SM was used, punctate labeling corresponding to 
labeled endosomes was readily seen in control cells (Fig. 4 
A), but intracellular labeling was inhibited in ATP-depleted 
ceils (Fig. 4  B).  These ATP-depletion conditions also in- 
hibited the internalization of Texas red dextran (see Materials 
and Methods), a fluid phase endocytic marker (Koval and 
Pagano,  1990)  (data  not  shown).  In  contrast,  when  Cs- 
DMB-GIcCer (Fig. 5) or Cs-DMB-GalCer were used (data 
not shown), punctate labeling was inhibited by ATP deple- 
tion (compare Fig. 5, B vs A), but labeling of the endoplas- 
mic reticulum, mitochondria, and nuclear envelope were not 
affected. As in control cells (see above),/>98 % of the cell- 
associated  fluorescence in lipid extracts of ATP-depleted 
cells was from Cs-DMB-GlcCer (data not shown). Interest- 
ingly, ATP depletion appeared to reduce the accumulation of 
Cs-DMB-GlcCer at the Golgi apparatus  (Fig.  5 B,  right 
panel). 
We also examined the effect of temperature on CrDMB- 
GlcCer internalization (Fig. 6).  Cells were incubated with 
Cs-DMB-GlcCer for 30 min at 2°C, washed, and warmed 
to 10°C (2 h), 19°C (2 h), or 37°C (15 min) before back ex- 
change with DF-BSA. While treatment of cells at 10°C in- 
hibited internalization (Fig. 6 A), labeling of intracellular 
membranes was readily seen at 19°C (Fig. 6 B), as well as 
37°C (Fig. 6  C). 
Evaluation of  Potential Inhibitors of 
CrDMB-GIcCer Transport from the Plasma 
Membrane to IntraceUular Membranes 
Finally, we evaluated the effects of numerous reagents on the 
redistribution of CrDMB-GIcCer from the plasma mem- 
brane  to  intracellular  membranes  (Table  II).  Cells  were 
treated with various (a) inhibitors, (b) structural analogues 
of glucose or glucose transport inhibitors, (c) sphingolipid 
analogues, (d) protein modification reagents, (e) enzymes, 
(f) modifiers of cellular cholesterol, or (g) other reagents. 
With one exception, none of these reagents had an effect on 
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 Figure 6. Effect  of temperature on the intraceUular redistribution 
of Cs-DMB-GIcCer. Cells were incubated with Cs-DMB-GIcCer/ 
BSA for 30 rain at 2"C, washed, warmed for (,4) 2 h at 10*C, (B) 
2 h at 19"C, or (C) 15 rain at 37"C before back exchange with 
DF-BSA. The samples were then photographed at green  +  red 
wavelengths. Bar, 10 t~m. 
the intracellular labeling seen with Cs-DMB-GlcCer. Treat- 
ment of cells with a nonfluorescent GlcCer (Fig. 7 B) (but 
not GalCer; Fig. 7 C) analogue at a high concentration re- 
duced labeling of the Golgi apparatus by Cs-DMB-GlcCer 
compared to control cells (Fig. 7 A).  (In this experiment, 
Cs-DMB-GIcCer was added before addition of the nortfluo- 
rescent GlcCer and GalCer analogues so that both control 
cells and cells treated with the nonfluorescent  glycolipid  ana- 
logues would contain the same amount of fluorescent lipid 
[see legend of Fig. 7].) This result suggests that accumula- 
tion of Cs-DMB-GlcCer at the Golgi apparatus may be a 
saturable process. 
Discussion 
In this paper,  we investigated the uptake and intracellular 
transport  of a  fluorescent analogue of glucosylceramide, 
Cs-DMB-GlcCer, and compared it to the behavior of three 
other fluorescent sphingolipid analogues (Cs-DMB-GalCer, 
Cs-DMB-LacCer, and Cs-DMB-SM),  which also label the 
plasma membrane of human skin fibroblasts during incuba- 
tions  at low  temperatures.  We provide evidence that C~- 
DMB-GlcCer and  Cs-DMB-GalCer  are internalized by a 
combination of  endocytosis and transbilayer movement ("flip 
flop") at the plasma membrane and endosomes. This latter 
process results in labeling of intracellular membranes and 
accumulation of  the fluorescent lipids at the Golgi apparatus. 
In contrast, Cs-DMB-SM and Cs-DMB-LacCer appear to 
be internalized primarily by endocytosis, producing a punc- 
tate fluorescence pattern that is readily distinguished from 
that obtained with the Cs-DMB-GlcCer and Cs-DMB-Gal- 
Cer analogues. 
Intracellular Transport of  C~-DMB-SM 
and CrDMB-LacCer 
Fig. 8 A shows a model for the movement of Cs-DMB-SM 
and Cs-DMB-LacCer from the plasma membrane to intra- 
cellular membranes.  These  lipids  are  integrated into the 
plasma membrane bilayer during incubation at low tempera- 
ture. During subsequent warming to 37°C, the fluorescent 
lipid is internalized into numerous fluorescent vesicles that 
are scattered throughout the cytoplasm (Fig. 2, A and B), 
and,  by  analogy to  previous  studies  with another sphin- 
gomyelin analogue, correspond to labeled endosomes (Koval 
and Pagano, 1990). This internalization process was ATP de- 
pendent (Fig. 4) and inhibited at low temperature (data not 
shown). Cs-DMB-SM could be almost completely removed 
from the cell surface after the low temperature labeling (see 
Table I) by incubation with defatted BSA at low temperature 
(back exchange), suggesting that the fluorescent lipid was 
present in the outer leaflet of the plasma membrane bilayer. 
The presence of discrete "punctate dots" of fluorescence, 
rather than a more generalized labeling of many different in- 
tracellular membranes, suggests that Cs-DMB-SM and Cs- 
DMB-LacCer were restricted to the lumenal leaflet of endo- 
cytic vesicles (topologically equivalent to the outer leaflet of 
the plasma membrane bilayer) during internalization and, 
therefore, unable to equilibrate and label other cellular mem- 
branes.  This idea  is  consistent with our finding that Cs- 
DMB-SM (as well as other C~-DMB-lipids)  labeled many 
different intracellular membranes in perforated cells where 
the plasma membrane was disrupted and a barrier to trans- 
membrane movement of lipids no longer existed (Fig. 3 B). 
In addition to labeling of endosomes, some labeling of the 
Golgi apparatus was also seen when Cs-DMB-SM or Cs- 
DMB-LacCer were used; (e.g., Fig. 2, A and B). This most 
likely results from hydrolysis of these lipids at the plasma 
membrane and/or lysosomes and subsequent transport of  the 
resulting fluorescent ceramide to the Golgi apparatus CKoval 
Martin and Pagano Transport of Glucosylceramide  777 Table II. Effects of Various Reagents on the Accumulation of CrDMB-GlcCer at the Golgi Apparatus of Human 
Skin Fibroblasts* 
Pretreatment 
conditions 
Treatment  Concentration  Temp.  Time 
Present 
throughout 
experiment 
Acanndiates at 
Golgi  apparatus 
°C  m/n 
Inhibitors 
Sodium azide  +  5  mM 
2-deoxyglucose*  50 mM 
NI-LC1  20 mM 
Chloroquine  20/~M 
Structural analogues of glucose; glucose transport inhibitors 
Glucose  5  mM  37 
Galactose  5  mM  37 
Glucose-l-phosphate  5  mM  37 
Glucosamine  5  mM  37 
~3-v-Glucuronic acid  5  mM  37 
X-Glu, X-Gal  1 mM  37 
Cytochalasin B  50 #M  37 
Sphingolipid analogues 
PDMP  20 #M 
C2-GalCerll  100 #M 
C2-GlcCerll  100 #M 
C6-GalCerll  100 #M 
C6-GlcCerll  100 #M 
Protein modification reagents 
NEM¶  0.5 mM  2 
Fixation**  22 
DIDS  1 mM  2 
SITS  1 mM  2 
Enzymatic treatments 
Trypsin  12.5  gg/ml  2 
Neuraminidase  2.5 #g/ml  2 
Endoglycoceramidase  1.5 mU/ml  37 
Sphingomyelinase  0.13  mU/ml  37 
Modification of cellular 
cholesterol 
Cholesterol oxidase  10 IU/ml  37 
Lovastatin  10 #M  37 
Other reagents 
Brefeldin A  5  #g/ml  37 
Nocodazole  10 #g/ml  37 
Verapamil  200 #M  37 
37 
None 
None 
None 
None 
None 
None 
None 
30  +  :t:0 
+  + 
+  + 
30  +  + 
30  +  + 
30  +  + 
30  +  + 
30  +  + 
30  +  + 
30  +  + 
+  + 
+ll  + 
-4-II  -4- 
+ tl  + 
+ll 
30  -  + 
30  -  + 
30  -  + 
30  -  + 
30  -  + 
30  -  + 
30  -  + 
15  -  + 
10  -  + 
24 hr  -  + 
30  +  + 
90  +  + 
30  +  + 
* Except for treatment with some of the sphingolipid analogues (see fourth footnote), cell cultures on glass coverslips were washed with HMEMB and preincubated 
(if indicated) with each reagent at the indicated concentration,  temperature,  and time. The cells were then washed, incubated with 10 ~M Cs-DMB-GIcCer/BSA 
for 30 rain at 2°C, washed, warmed to 37°C for 15-30 min, back exchanged, and examiAed for intracellular  fluorescence.  Where indicated,  the reagents were 
also present throughout the experiment; i.e., during incubation with Cs-DMB-GIcCer,  during warming and back exchange, and during the microscopic observa- 
tion. Parallel  control cultures  showed intracellular  fluorescence  similar to that in Fig. 1, C and D. 
ATP depletion was performed as described (Martin and Pasano, 1987) by pretreafing cells with 5 mM NaN3 and 50 mM 2-deoxyglucose in glucose-free HMEMB 
for 30 rain at 37°C, and performing all subsequent incubations  and washes in glucose-free  HMEMB containing  these inhibitors. 
t  +, Prominent labeling of the Goigi apparatus,  e.g., as in Fig. 5 A;  ±, reduced accumulation  at the Golgi apparatus  as in Fig. 5 B;  -,  minimal labeling of 
the Golgi apparatus  as in Fig. 7 B. 
II Cell cultures  on glass coversllps were washed with HMEMB, incubated with 2.5 ~tM C~-DMB-GIcCer/BSA for 30 rain at 2°C, washed, and warmed for 15 
rain at 37°C in the presence of each sphingnlipid analogue/BSA  complex (see Materials  and Methods). The cells were then both back exchanged and observed 
in the presence of each sphingolipid  analogue/BSA  complex. 
¶ N-ethylmaleimide treatment was followed by a 5-rain treatment on ice with 0.5 mM DTr in HMEMB and washing with HMEMB before incubation with Cs-DMB- 
GIcCer/BSA. 
** Fixative  contained 3% paraformaldehyde  and 0.02% glutsraldehyde in PBS. 
The Journal  of Cell Biology,  Volume 125, 1994  778 Figure 7. A nonfluorescent  GlcCer analogue reduces accumulation 
of CrDMB-GlcCer  at the Golgi apparatus. Cells were incubated 
with 2.5/zM Cs-DMB-GIcCer/BSA for 30 rain at 2°C, washed, 
and warmed for 15 rain at 37°C in the presence of (,4) BSA alone, 
(B)  100/~M C6-GlcCer/BSA, or (C)  100/zM  C6-GalCer/BSA. 
The samples were then back exchanged  in the absence (A) or pres- 
ence (B and C), of nonfluorescent C~-sphingolipid/BSA,  and pho- 
tographed at green + red wavelengths.  Note the prominent labeling 
of the Golgi apparatus in (,4) and (C) relative to that in (B). Bar, 
10 ~m. 
and Pagano,  1990),  which has a high affinity for ceramide 
(Lipsky  and  Pagano,  1985;  Pagano  et  al.,  1989,  1991; 
Pagano,  1990b;  Rosenwald and Pagano,  1993). 
IntraceUular  Transport of CrDMB-GIcCer 
Incubation of cells with CrDMB-GIcCer/BSA resulted in a 
markedly different pattern of intracellular fluorescence than 
that seen with Cs-DMB-SM  and CrDMB-LacCer.  When 
cells were treated with C~-DMB-GIcCer/BSA  and subse- 
quently warmed to 37°C, the fluorescent lipid redistributed 
into punctate dots of fluorescence throughout the cytoplasm 
and rapidly into other intracellular membranes; e.g., the nu- 
clear envelope and Golgi apparatus. A working model for the 
intracellular transport of C~-DMB-GlcCer is given in Fig. 8 
B and discussed below. 
Transbilayer Movement of Cs-DMB-GIcCer at the Plas- 
ma Membrane and Subsequent  Labeling of IntraceUular 
Membranes. During low temperature incubation, CrDMB- 
GlcCer labeled the plasma membrane. However, 25-30% of 
the Cs-DMB-GlcCer  incorporated into  the plasma mem- 
brane at low temperature was resistant to back exchange with 
defatted BSA (Table I). One possible explanation for this ob- 
servation is that a portion of the CrDMB-GIcCer was trans- 
ported to the inner leaflet of the plasma membrane bilayer, 
where it became inaccessible to back exchange with defatted 
BSA (Fig. 8 B, step I).  Such a mechanism is the case for 
fluorescent analogues of  phosphatidylethanolamine  and phos- 
phatidylserine, which label the plasma membrane of Chi- 
nese hamster fibroblasts and undergo transbilayer  movement 
at low  temperature  (Martin and Pagano,  1987).  Alterna- 
tively, a portion of the Cs-DMB-GIcCer at the cell surface 
might interact with other cell surface constituents, reducing 
the size of the back-exchangeable pool of this lipid. Once 
present on the cytoplasmic leaflet of the plasma membrane, 
Cs-DMB-GIcCer  could move by  spontaneous or protein- 
mediated diffusion to label other intracellular membranes 
(Fig.  8 B, step II).  As discussed above for Cs-DMB-SM, 
such an explanation is consistent with our observations of 
Cs-DMB-GlcCer distribution in perforated cells after low 
temperature incubations. 
Transbilayer Movement of CrDMB-GIcCer during En- 
docytosis and Subsequent Labeling of IntraceUular Mem- 
branes. During warming to 37°C,  some Cs-DMB-GIcCer 
also enters the cell by an endocytic route (Fig. 8 B, step III). 
Indeed, inhibition of endocytosis by ATP depletion elimi- 
nated the presence of punctate fluorescence in the cyto- 
plasm, which most likely corresponds to endosomes, but 
otherwise had little effect on labeling of other intracellular 
membranes (compare Fig. 5, A and B, left panels). 
It is likely that transbilayer movement of C~-DMB-Glc- 
Cer also occurs in endosomes (Fig. 8 B, step IV), since in 
the time course experiment of Cs-DMB-GlcCer distribution 
(Fig.  1), fluorescence was initially seen primarily in endo- 
somes,  while at later times, fluorescence was widely dis- 
tributed in other intracellular membranes and reduced in 
vesiclelike structures. However,  transport of Cs-DMB-Glc- 
Cer  from endosomes to  lysosomes was  not required  for 
labeling of the nuclear envelope, Golgi apparatus, and other 
intracellular membranes, since labeling of these membranes 
also occurred at 19°C (Fig. 6 B), a temperature at which 
vesicular transport between endosomes and lysosomes is 
blocked (Dunn et al.,  1980;  Aulinskas et al.,  1982). 
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Figure 8. Working  model for internaliTation  of fluorescent sphingolipid  analogues from the plasma membrane to intracellular membranes. 
Thick lines represent portions of the bilayer containing fluorescent lipid. (,4) Cs-DMB-SM and Cs-DMB-LacCer, initially present in the 
outer leaflet of the plasma membrane brayer, are restricted to the lumenal leaflet of endocytic vesicles and produce a punctate pattern 
of  intracelinlar fluorescence  during internalization. These lipids are also slowly  transported to the lysosomes  along the degradative  pathway 
(see Koval and Pngano, 1990). A portion of the fluorescent sphingomyelin  is degraded by a neutral sphingomyelinase  at the plasma mem- 
brane and an acidic sphingomyelinase  in the lysosomes. The ceramide formed by this process subsequently stains the Golgi apparatus. 
(B) Cs-DMB-GIcCer and Cs-DMB-GalCer, initially present in the outer leaflet of the plasma membrane brayer, undergo transbilayer 
movement to the cytosolic surfaces of the plasma membrane and endosomes. These fluorescent lipids are then able to label numerous 
intracellular membranes including the Golgi apparatus, where they accumulate. Roman numerals, steps of the internalization  process dis- 
cussed in text. 
The  process  of  Cs-DMB-GIcCer  transport  from  the 
plasma membrane'and endosomes to label other intracellu- 
lar membranes was inhibited at 10°C (Fig. 6), but not by a 
wide variety of drugs, inhibitors, and enzymatic treatments 
(Table H). Thus, it seems likely that the transbilayer move- 
ment of Cs-DMB-GlcCer at the plasma membrane and en- 
dosomes and subsequent labeling of intraceilular membranes 
by this lipid was not the result of a protein-mediated process, 
although we cannot completely exclude this possibility. 
It is interesting to note that the intracellular distribution 
of Cs-DMB-GalCer was similar to that seen with Cs-DMB- 
GlcCer, except that more vesicle-like structures and weaker 
labeling of the Golgi apparatus were seen when Cs-DMB- 
GalCer was used (compare Fig. 2,  C vs D). This observa- 
tion, along with our finding that Cs-DMB-GalCer is effi- 
ciently removed from the cell surface by back exchange 
(Table  I),  suggests  that Cs-DMB-GalCer undergoes trans- 
bilayer movement at the plasma membrane and endosomes 
more slowly than Cs-DMB-GIcCer. 
Accumulation of Cs-DMB-GIcCer at the Golgi  Appara- 
tus.  The mechanism for accumulation of Cs-DMB-GlcCer 
at the Golgi apparatus (Fig. 8 B, step V) is unknown. In- 
terestingly, incubation of ceils with a non-fluorescent ana- 
logue of GlcCer (but not GalCer) reduced the labeling of the 
Golgi apparatus by C5-DMB-GIcCer (compare Fig. 7, A vs 
B), although it is not clear whether this analogue directly in- 
hibited the accumulation of Cs-DMB-GIcCer at the Golgi 
apparatus, or reduced the labeling there because transport of 
Cs-DMB-GlcCer  from  the  plasma  membrane and  endo- 
somes to intracellular membranes was slowed. In addition, 
labeling of the Golgi apparatus by Cs-DMB-GIcCer was re- 
duced in ATP-depleted cells (compare Fig. 5, A vs B, right 
panels),  suggesting that accumulation of the GlcCer ana- 
logue at this organelle might be an energy-dependent pro- 
cess. The accumulation of a fluorescent analogue of phos- 
phatidylserine at the Golgi apparatus is also ATP-dependent 
(Kobayashi and Arakawa,  1991). 
One intriguing possibility for the a~umulalion of C5-DMB- 
GlcCer at the Golgi apparatus is related to the synthesis of 
endogenous  GlcCer.  Previous  studies  have  demonstrated 
that GlcCer synthase is enriched at the Golgi complex, and 
that synthesis of GlcCer occurs on the cytosolic surface of 
membrane vesicles derived from this organelle (Coste et al., 
1985, 1986; Futerman and Pagano, 1991; Jeckel et al., 1992; 
Trinchera et al.,  1991). These findings imply that after its 
synthesis, GlcCer must undergo transbilayer movement to 
the lumenal surface to account for the known topology of 
higher order glycosphingolipids within the Golgi apparatus 
and plasma membrane. Thus, it is tempting to speculate that 
Cs-DMB-GlcCer  accumulates at the Golgi apparatus  be- 
cause it uses the same molecular machinery present at the 
Golgi apparatus for transbilayer movement of newly synthe- 
sized endogenous GlcCer. 
Sorting of  Sphingolipids in the Endocytic Pathway 
The intracellular transport of N-(N-[6-[(7-nitrobenz-2-oxa- 
The Journal  of Cell Biology,  Volume 125, 1994  780 1,3-diazol-4-yl)amino]  hexanoyl]) glucosyl sphingosine (C6- 
NBD-GIcCer) has been examined  in several cell types and 
its  internalization  from  the  plasma  membrane compared 
with  the  corresponding  analogue  of  sphingomyelin,  C6- 
NBD-SM  (K_ok et  al.,  1989,  1991,  1992).  Evidence  is 
presented that in the human colon adenocarcinoma  cell line 
HT29, C6-NBD-GIcCer and C6-NBD-sphingosylphosphoryl- 
choline are sorted during internalization along the endocytic 
pathway CKok et al.,  1991); i.e.,  while C~-NBD-GlcCer  is 
transported  to  the  Golgi  apparatus,  C6-NBD-sphingosyl- 
phosphorylcholine moves predominantly  to the lysosomes. 
Although the  mechanism for the  sorting  of these  sphin- 
golipid analogues is unknown, it was suggested  that these 
lipids separate from one another by sequestration into differ- 
ent membrane domains that enter different populations of en- 
dosomes (Hoekstra and Kok,  1992). While the present study 
was  carried  out using  different  fluorescent  analogues  of 
GlcCer and sphingomyelin  and a different cell type, it raises 
the possibility that these lipids may segregate from one an- 
other upon internalization  from the plasma membrane be- 
cause they use endocytic and nonendocytic  uptake mecha- 
nisms to different extents. 
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